A TLR5 mono-agonist restores inhibited immune responses to Streptococcus pneumoniae during influenza virus infection in human monocytes.
Influenza A virus (IAV) predisposes individuals to often more severe secondary bacterial infections with Streptococcus pneumonia (S. pneumoniae). The outcomes of these infections may be made worse with the increase in antimicrobial resistance and a lack of new treatments to combat this. Th17 respons...
Guardado en:
Autores principales: | Paula T Maguire, Sinéad T Loughran, Ruth Harvey, Patricia A Johnson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/126bb045368d4fa68f4b6426253b4b4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Contextualization procedure and modeling of monocyte specific TLR signaling.
por: Maike K Aurich, et al.
Publicado: (2012) -
Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease
por: Zhiming Wang, et al.
Publicado: (2020) -
Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
por: Sathana Dushyanthen, et al.
Publicado: (2017) -
Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry
por: Takahiro Sawada, et al.
Publicado: (2021) -
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
por: Zhang,Li, et al.
Publicado: (2015)